Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.

Annals of hematology - 1 Feb 2018

Duong Vu H, Padron Eric, Al Ali Najla H, Lancet Jeffrey E, Hall Jeff, Kwok Brian, Zhang Ling, Epling-Burnette Pearlie K, List Alan F, Komrokji Rami S

Abstract excerpt

The prognostic value of peripheral blasts (PB) is not well-studied in patients with myelodysplastic syndromes (MDS). We evaluated the impact of PB on overall survival (OS) and transformation to acute myeloid leukemia (AML) in a large cohort. The MDS database at the Moffitt Cancer Center was retrospectively reviewed to identify patients with ≥ 1% PB (PB-MDS) and those without PB (BM-MDS). We also assessed the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Karyotype

Share to Leukemia, Myeloid, Acute

Share to Myelodysplastic Syndromes

Share to Neoplasm Proteins

Share to Neoplastic Cells, Circulating

Share to Survival Analysis

Source

Identifiers

PMID: 29167940
DOI: 10.1007/s00277-017-3186-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.PMID 29167940Read ↗

The current and future role of stem cells in myelodysplastic syndrome therapies.Semantic proximity Read ↗

Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis.Semantic proximity Read ↗

Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes.Semantic proximity Read ↗

The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes.Semantic proximity Read ↗

Myelodysplastic syndrome is not merely “preleukemia”Semantic proximity Read ↗

Prognostic Markers of Myelodysplastic Syndromes.Semantic proximity Read ↗

[Clinical features of SF3B1 mutation in patients with myelodysplastic syndrome with excess blasts].Semantic proximity Read ↗

Evaluating the prognosis of patients with myelodysplastic syndromes.Semantic proximity Read ↗

Myelodysplastic Syndromes: How to Recognize Risk and Avoid Acute Myeloid Leukemia Transformation.Semantic proximity Read ↗

[Risk factors for leukemia transformation in patients with myelodysplastic syndromes].Semantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

MDS prognostic scoring systems – past, present, and future.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.